Label: CPDA-1- anticoagulant citrate phosphate dextrose adenine solution

  • DEA Schedule: None
  • Marketing Status: New Drug Application

Drug Label Information

Updated November 19, 2019

If you are a consumer or patient please visit this version.

  • Anticoagulant Citrate Phosphate Dextrose Adenine Solution (CPDA-1) BLOOD-PACK™ Unit

    Rx only

    Integral Donor Tube (IDT).

    Use aseptic technique.

    Caution: Do not use unless anticoagulant is clear.

    Identify BLOOD-PACKunit using appropriate donor identification system.
    Adjust donor scale to desired collection/weight/volume.
    Position primary container on the donor scale as far as possible below donor arm and clamp donor tubing with hemostat.
    Apply pressure to donor’s arm and disinfect site of venipuncture.
    If blood pressure cuff is used, inflate to approximately 60 mm Hg.
    Remove needle cover per instructions below:
    Holding the hub and cover near the tamper-evident seal, twist cover 1/4 turn to break seal.
    Remove needle cover, being careful not to drag the cover across the needle point.
    Perform venipuncture, appropriately secure donor needle and/or tubing and release hemostat.
    Mix blood and anticoagulant at several intervals during collection and immediately after collection.
    Collect the appropriate volume based on BLOOD-PACK unit used. Note: The volume of anticoagulant is sufficient for the blood collection indicated on BLOOD-PACK unit ± 10%.
    Apply hemostat to donor tubing.
    As appropriate, release pressure on the donor’s arm, collect donor samples following established procedures and withdraw donor needle.
    Precaution: Use care to avoid accidental needle sticks. A Needle Protector System may be used to reduce the risk of needle stick injury.
    Strip blood from donor tubing into container, mix and allow the tubing to refill; repeat once. Seal at X marks on donor tubing to provide numbered aliquots of anticoagulated blood for typing or crossmatching.
    Discard needle into an appropriate biohazardous waste container following established procedures.
    Store suspended CPDA-1 whole blood/red blood cells between 1 and 6ºC.
    Infuse CPDA-1 whole blood/red blood cells within 35 days of collection.

    For further processing with multiple BLOOD-PACK units, use standard component processing techniques.

    Definition of Symbols:


    Dispose of container appropriately.

    Single use only.

    Do not use if there is any visible sign of deterioration.

    Do not vent.

    Sterilized by steam. Sterile fluid path.

    Non-pyrogenic fluid path.

    Store at Controlled Room Temperature.
    USP Definition of “Controlled Room Temperature” United States Pharmacopeia, General Notices.
    United States Pharmacopeial Convention, Inc.
    12601 Twinbrook Parkway, Rockville, MD

    logoManufactured by:
    Fenwal, Inc.
    Lake Zurich, IL 60047 USA

    Made in USA

    Fenwal International, Inc.
    Road 357, Km. 0.8
    Maricao, PR 00606

    Imported and distributed in India by:
    Fenwal India Pvt Ltd
    Upper Ground Floor, Tower B
    DLF Building No. 10, DLF Cyber City
    DLF Phase-II, Gurgaon 122 002,
    Haryana, India
    Import License No.: FF-504-14890

    FENWAL and BLOOD-PACK are trademarks of Fenwal, Inc.

    07-19-04-284 REV: A

    © 2010 Fenwal, Inc. All rights reserved.


    REF R4R7634

    6 Units


    Triple BLOOD-PACKUnitAnticoagulant Citrate PhosphateDextrose Adenine Solution (CPDA-1)

    PL 146 Plastic

    Rx only

    Triple BLOOD-PACKunit consisting of a primary pack containing 49 mL of CPDA-1 anticoagulant solution and two transfer packs without solution for collection of 350 mL of blood, 16 gauge needle.

    See instructions for use. Sterile, non-pyrogenic fluid path. Steam sterilized. Single use only. Do not vent. Do not use if there is any visible evidence of deterioration. Dispose of container appropriately. Store at Controlled Room Temperature (refer to direction insert).

    Unused packs in open foil pouch may be kept to 60 days by folding and securing open end of foil pouch, to prevent possible loss of moisture.

    Direct handling of product surfaces prior to extended storage in the foil pack may result in mold growth.

    Each 49 mL CPDA-1 solution contains 1.56 g Dextrose (monohydrate), USP, 1.29 g Sodium Citrate (dihydrate), USP, 160 mg Citric Acid (monohydrate), USP, 109 mg Monobasic Sodium Phosphate (monohydrate), USP, 13.5 mg Adenine, USP, Water for Injection USP to 49 mL.

    logoManufactured by:
    Fenwal International, Inc.
    oad 357, Km. 0.8
    aricao, PR 00606

    Made In USA

    Imported and distributed in Indonesia by:
    PT.Medquest Jaya Global
    Menara Salemba 6th Floor
    Jl.Salemba Raya Kav 5-5A
    Jakarta-Indonesia 10440
    Reg. No.: See Instructions for use.

    Imported and distributed in India by:
    Fenwal India Pvt Ltd
    Upper Ground Floor, Tower B
    DLF Building No. 10, DLF Cyber City
    DLF Phase-II, Gurgaon 122 002,
    Haryana, India
    Import License No.: FF-504-14890
    MRP: Rs. 239 (inclusive of all taxes)

    FENWAL and BLOOD-PACK are trademarks of Fenwal, Inc.

    PL 146 is a trademark of Baxter International, Inc.

    07-28-04-287 REV: A

    Triple BLOOD-PACK™ UnitAnticoagulant Citrate PhosphateDextrose Adenine Solution (CPDA-1) label
    anticoagulant citrate phosphate dextrose adenine solution
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0942-6329
    Route of AdministrationINTRAVENOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    Dextrose Monohydrate (UNII: LX22YL083G) (ANHYDROUS DEXTROSE - UNII:5SL0G7R0OK) Dextrose Monohydrate1.56 g  in 49 mL
    Trisodium Citrate Dihydrate (UNII: B22547B95K) (Anhydrous Citric Acid - UNII:XF417D3PSL) Anhydrous Citric Acid1.29 g  in 49 mL
    Anhydrous Citric Acid (UNII: XF417D3PSL) (Anhydrous Citric Acid - UNII:XF417D3PSL) Anhydrous Citric Acid147 mg  in 49 mL
    Sodium Phosphate, Monobasic, Monohydrate (UNII: 593YOG76RN) (PHOSPHATE ION - UNII:NK08V8K8HR) Sodium Phosphate, Monobasic, Monohydrate109 mg  in 49 mL
    Adenine (UNII: JAC85A2161) (Adenine - UNII:JAC85A2161) Adenine13.5 mg  in 49 mL
    Inactive Ingredients
    Ingredient NameStrength
    Sodium Hydroxide (UNII: 55X04QC32I)  
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0942-6329-0349 mL in 1 BAG; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    Labeler - Fenwal, Inc. (794519020)
    NameAddressID/FEIBusiness Operations
    Fenwal International, Inc.091164590MANUFACTURE(0942-6329)